The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1594-1602

  Majumdar, S ^b   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Enhancer; Mutations; Promoter; Prostate specific antigen gene

Indexed keywords

ANDROGEN; DNA; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE; STEROID;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CYTOSOL; DISEASE CLASSIFICATION; DNA POLYMORPHISM; ENHANCER REGION; EXON; GENE AMPLIFICATION; GENE CONTROL; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0006980153     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690254     Document Type: Article

References (35)

1. Ahe D, Janich S, Scheidereit C, Renkawitz R, Schutz G and Beato M (1985) Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature, 313: 706-709
2. Cairns C, Gustafsson J-A and Carlstedt-Duke J (1991) Identification of protein contact sites within the glucocorticoid/progestin response element. Mol Endocrinol 5: 598-604
3. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Caplen DE, Yuan JJ, Petros JA and Andriole GL (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161
4. Cleutjens KBJM, van der Korput HAGM, van Eekelen CCEM, van Rooij HCJ, Faber PW and Trapman J (1997) An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 11: 148-161
5. Digby M, Zhang X-Y and Richards RI (1989) Human prostate specific antigen (PSA) gene: structure and linkage to the kallikrein-like gene, hGK-I. Nucleic Acids Res 17: 2137
6. Ferguson RA, Yu H, Kalyvas M, Zammit S and Diamandis EP (1996) Ultrasensitive detection of prostate specific antigen by time-resolved immunofluorometric assay and the immulite immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem 42: 536-544
7. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrad DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199
8. Henntu P, Liao S and Vikho P (1992) Androgens upregulate the human prostate specific antigen messenger ribonucleic acid, but down-regulate the prostatic phosphatase mRNA in LNCaP cells. Endocrinology 130: 766-772
9. Levesque M, Yu H, D'Costa M and Diamandis EP (1995) Prostate specific antigen expression by various tumors. J Clin Lab Anal 9: 123-128
10. Lilja H (1985) A kallikrein like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76: 1899-1903
11. Lundwall A (1989) Characterization of the gene for prostate specific antigen, a human glandular kallikrein. Biochem Biophys Res Commum 161: 1151-1159
12. McCormak RT, Rittenhouse HG, Finlay JA, Sokoloff, RL, Wang TJ, Wolfert RL, Lilja H and Oesterling JE (1995) Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45: 729-744
13. MacDonald RJ, Margolius HS and Erdos EG (1988) Molecular biology of tissue kallikrein. Biochem J 253: 313-321
14. Manialis T, Fritsch EF and Sambrook J (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
15. Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923
16. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB and Davidson NE (1994) Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2555
17. Pisani P, Parkin DM and Ferlay J (1985) Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden. Int J Cancer 55: 891-903
18. Riegman PHJ, Vlietstra RJ. van der Korput JAGM, Romijn JC and Trapman J (1989) Characterization of the prostate specific antigen gene: a novel human kallikrein-like gene. Biochem Biophys Res Commun 159: 95-102
19. Riegman PHJ, Vliestra RJ, Korput JAGM, Romijn JC and Trapman J (1991) Identification and androgen regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol Cell Endocrinol 76: 181-190
20. Riegman PHJ, Vlietstra RJ, Suurmeijer L, Cleutjens CBJM and Trapman J (1992) Characterization of the human kallikrein locus. Genomics 14: 6-11
21. Sauter ER, Daly M, Lenahan K, Ehya H, Engstrom PF, Sorling A, Bonney G, Yu H and Diamandis EP (1996) Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 967-970
22. Schedlich LJ, Bennetts BH and Morris BJ (1987) Primary structure of a human glandular kallikrein gene. DNA 6: 429-437
23. Schulz P, Stucka R, Feldmann H, Combriato G, Klobeck H-G and Fittler F (1998) Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence. Nucleic Acids Res 16: 6226
24. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG and Henderson DR (1996) Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem 271: 7043-7051
25. Smith MNR, Biggar S and Hussain M (1995) Prostate specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 55: 2640-2644
26. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS and Redwine E (1987) Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916
27. Truss M and Beato M (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrinol Rev 14: 459-479
28. Tsuyuki D, Grass L, Diamandis EP (1997) Frequent detection of mutations in the 5′ flanking region of the prostate specific antigen gene in female breast cancer. Eur J Cancer 33: 1853-1856
29. Watt KW, Lee PJL, M'Timkulu T, Chan WP and Loor R (1986) Human prostate-specific antigen: structural and functional similarity with serine protease. Proc Natl Acad Sci USA 83: 3166-3170
30. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419
31. Young CYF, Andrews PE, Montgomery BT and Tindall DJ (1992) Tissue specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31: 818-824
32. Yu H, Diamandis EP, Zarghami N and Grass L (1994) Induction of prostate specific antigen production by steroid and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 291-300
33. Yu H, Diamandis EP, Katsaros D, Sutherland DIA, Levesque MA, Roagna R, Ponzone R and Sismondi P (1995) Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110
34. Yu H, Diamandis EP, Levesque M, Asa SL, Monne M and Croce CM (1995) Expression of the prostate specific gene by a primary ovarian carcinoma. Cancer Res 55: 1603-1606
35. Zarghami N, Grass L and Diamandis EP (1997) Steroid hormone regulation of prostate specific antigen gene expression in breast cancer. Br J Cancer 33: 579-588